Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle - ScienceDirect
Antibodies | Free Full-Text | Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study | PLOS
Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis | Scientific Reports
Anti-Drug Antibody Assays with Next Generation Protein Sequencing
Anti-drug antibodies in the current management of cancer | SpringerLink
Anti-Drug Antibody Assays for clinical or non-clinical specimens | vivo Science GmbH